United States · FDA National Drug Code directory
TOPIRAMATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-184_62911647-4208-47b3-a9af-67f026411019
- Product NDC
- 31722-184
- Form
- TABLET
- Composition / generic term
- Topiramate
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210922
- Source listing expiry
- 20261231
Source-listed ingredients
- TOPIRAMATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (31722-184-05) · 31722-184-05
- 60 TABLET in 1 BOTTLE (31722-184-60) · 31722-184-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →